American Shared Hospital Services (AMS) Stock Price & Analysis
American Shared Hospital Services (AMS) closed at USD 1.26 on Friday, October 23, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 1.26; the Oct 23, 2026 session ranged USD 1.26–1.35 on volume of 3,665 shares. Market capitalization is $8.38M, with a 52-week range of USD 1.21–2.39 (ASE). Source: Nexqual, retrieved October 24, 2026 at 00:32 UTC.
Also available as compact Markdown for AI agents: nexqual.com/AMS.md
Key facts (AMS)
- Last four reported quarters (through Jun 30, 2026): revenue $30.4M, net income -$1.8M (-5.8% margin), free cash flow $3.5M (SEC filings).
- Analysts: None (1 analysts), mean target USD 4 (range 4–4).
- Total return with dividends: 1Y -44.3% vs S&P 500 +14.0%; 5Y -56.9% vs S&P 500 +76.9%.
- Next earnings: 2026-11-12, EPS estimate USD 0.01, revenue estimate $8.5M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (AMS)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $17.6M | $19.7M | $21.3M | $28.3M | $28.1M | $30.4M |
| Gross profit | $6.7M | $8.4M | $9.3M | $9.2M | $5.1M | — |
| Operating income | $1.4M | $2.4M | $270K | -$2.8M | -$3.6M | -$3.6M |
| Net income | $194K | $1.3M | $610K | $2.2M | -$1.6M | -$1.8M |
| EPS (diluted) | $0.03 | $0.21 | $0.10 | $0.33 | -$0.23 | — |
| Free cash flow | $4.6M | $6.8M | -$555K | -$7.8M | -$4.5M | $3.5M |
| Gross margin | 38.2% | 42.4% | 43.8% | 32.4% | 18.0% | — |
| Operating margin | 7.7% | 12.3% | 1.3% | -9.9% | -12.8% | -11.8% |
| Net margin | 1.1% | 6.7% | 2.9% | 7.7% | -5.5% | -5.8% |
| Revenue growth | -1.2% | +12.0% | +8.0% | +32.9% | -0.9% | — |
| Cash + short-term investments | $8.1M | $12.3M | $13.7M | $11.0M | $3.5M | — |
| Total debt | $15.7M | $13.7M | $13.3M | $20.4M | $17.4M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (AMS)
P/S 0.3x · EV/EBITDA 18.9x · EV/Sales 1.1x · P/FCF 2.4x · P/B 0.4x · FCF yield 42.19% · Earnings yield -21.17% · Net debt $25.9M · EV $34.3M
P/E at fiscal year-ends: Dec 2024 9.8x, Dec 2023 24.9x.
Analysts (AMS)
Consensus None, 1 analysts; mean target USD 4 (low 4, high 4).
Total return (dividends reinvested) (AMS)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -44.3% | -56.9% |
| S&P 500 (SPY) | +14.0% | +76.9% |
| Per year | -44.5% | -15.5% |
| Volatility (annualized) | 59.5% | 41.1% |
| Max drawdown | -45.4% (Feb 2026→Oct 2026) | -64.0% (Feb 2023→Oct 2026) |
AMS revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Direct Patient Services | $4.9M | 57.9% | +39.6% |
| Medical Equipment Leasing | $3.5M | 42.1% | -0.7% |
| Total revenue | $8.4M | 100% | — |
AMS revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Patient Income | $4.9M | 57.9% | +39.6% |
| Direct Patient Services | $4.9M | 57.9% | +39.6% |
| Rental Income From Medical Services | $3.5M | 42.1% | -0.7% |
| Medical Equipment Leasing | $3.5M | 42.1% | -0.7% |
| Pbrt Services | $2.3M | 27.8% | +22.1% |
| Total revenue | $8.4M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
AMS customer concentration
In the period ended Dec 31, 2025, 2 direct customers each accounted for at least 10% (31%, 26%) of revenue, per the company's 10-K filed Mar 31, 2026. The company does not name them.
AMS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.01 | $0.03 | -66.7% | $8.5M | 1 |
| Next quarter (ends Dec 2026) | $0.01 | $0.03 | -66.7% | $8.6M | 1 |
| Current fiscal year (ends Dec 2026) | $-0.14 | $-0.05 | +180.0% | $32.7M | 1 |
| Next fiscal year (ends Dec 2027) | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 00:32 UTC)
| Price | USD 1.26 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.26 |
| Open | USD 1.33 |
| Day Range | USD 1.26 – 1.35 |
| 52-Week Range | USD 1.21 – 2.39 |
| Volume | 3,665 shares |
| Market Cap | $8.38M |
| Exchange | ASE |
Technical Analysis (AMS)
Nexqual's technical model rates AMS "STRONG SELL" based on 0 bullish and 5 bearish signals across 126 daily candles, as of October 24, 2026 at 00:32 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 34.05 (neutral) |
| vs SMA50 | Below (USD 1.42) |
| MACD | -0.05 (negative) |
Analyst Ratings (AMS)
Wall Street analysts rate AMS "None" based on 1 analysts, with a mean price target of USD 4 (range USD 4–4), per Nexqual as of October 24, 2026 at 00:32 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 4 |
| High Target | USD 4 |
| Low Target | USD 4 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (AMS)
| Next Earnings Date | 2026-11-12 |
|---|---|
| EPS Estimate | USD 0.01 |
| Revenue Estimate | $8.53M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.07 vs est -0.02 ▼ miss |
| 2026-03-31 | USD -0.09 vs est -0.01 ▼ miss |
| 2025-12-31 | USD -0.09 vs est 0.02 ▼ miss |
| 2025-09-30 | USD 0 vs est 0 ▲ beat |
Source: Nexqual, October 24, 2026 at 00:32 UTC.
Financials & Fundamentals (AMS)
| Total Revenue | $30.41M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +19.20% |
| Gross Margin | +34.83% |
| Operating Margin | -7.22% |
| Profit Margin | -5.83% |
| ROE | -12.06% |
| Debt / Equity | 0.8 |
| Current Ratio | 0.78 |
| Total Cash | $6.51M |
| Total Debt | $20.52M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $3.54M (11.6% of revenue) |
Source: Nexqual, October 24, 2026 at 00:32 UTC.
Financial Health Score (AMS)
Nexqual rates American Shared Hospital Services's overall financial health "Weak" across five dimensions, as of October 24, 2026 at 00:32 UTC.
| Growth | Weak — Revenue -1% YoY (annual), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Weak — $7M cash and investments vs $32M debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $4M (last 4 quarters to Jun 2026, SEC), 12% margin |
| Efficiency | Critical — ROE -12%, ROA -2.4% |
Ownership (AMS)
| Insider Ownership | +34.72% |
|---|---|
| Institutional Ownership | +7.63% |
| Shares Outstanding | 6.65M |
| Float | 3.86M |
| Short % of Float | +0.17% |
Source: Nexqual, October 24, 2026 at 00:32 UTC.
Leadership (AMS)
American Shared Hospital Services is led by Craig K. Tagawa, President & Interim CEO, per Nexqual as of October 24, 2026 at 00:32 UTC.
| President & Interim CEO | Craig K. Tagawa |
|---|---|
| Executive Chairman | Raymond C. Stachowiak |
| Interim CFO, Chief Accounting Officer & Corporate Secretary | Alexis N. Tirrito |
| Senior Vice President of Sales & Marketing | Ranjit Pradhan |
| Vice President of International Sales & Marketing | Ernest R. Bates |
Major Backers & Investors (AMS)
Notable institutional backers of American Shared Hospital Services include DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio, LPL Financial LLC, Renaissance Technologies, according to Nexqual as of October 24, 2026 at 00:32 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 1.38% |
| LPL Financial LLC | 1.22% |
| Renaissance Technologies | 0.87% |
| NewEdge Advisors, LLC | 0.45% |
| James Investment Research, Inc. | 0.45% |
| Bridgeway Capital Management, LLC | 0.44% |
| Fidelity | 0.38% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Dimensional Fund Advisors | 1.54% |
| Vanguard Group | 1.22% |
| Geode Capital | 0.4% |
Source: Nexqual, October 24, 2026 at 00:32 UTC.
From American Shared Hospital Services's Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- American Shared Hospital Services ("ASHS" and, together with its subsidiaries, the "Company") is a leading provider of turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.
Partnerships
- On April 27, 2022, the Company signed a Joint Venture Agreement with the principal owners of Radioterapia Guadalupe Amor y Bien S.A. de C.V. ("Guadalupe") to establish AB Radiocirugia Y Radioterapia de Puebla, S.A.P.I. de C.V. of Puebla ("Puebla") to treat public- and private-paying cancer patients.
- On June 28, 2024, ASHS-Mexico signed a Joint Venture Agreement with Hospital San Javier, S.A. de C.V. ("HSJ") to establish Instituto Gamma Knife San Javier Mexico S.A.P.I. de C.V. ("San Javier") to provide radiosurgery services to public- and private-paying patients in Guadalajara, Mexico.
Legal & Regulatory Risks (Item 1A, quoted)
- Any failure, interruption, or breach in security of the Company's information technology ("IT") infrastructure due to a cyber-attack or other security incident could cause the Company to incur financial penalties and losses, reputational damage, and legal liability, which could have a material adverse effect on the Company's business, financial condition, and results of operations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INNV | InnovAge Holding Corp. | USD 9.55 | ▲ 0.32% |
| USPH | U.S. Physical Therapy, Inc. | USD 88.53 | ▼ 0.23% |
| NUTX | Nutex Health Inc. | USD 209.59 | ▲ 1.7% |
| PNTG | The Pennant Group, Inc. | USD 41.88 | ▼ 0.83% |
| AGL | agilon health, inc. | USD 89.71 | ▼ 0.64% |
| CMPS | COMPASS Pathways Plc - American | USD 11.18 | ▼ 3.87% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 00:32 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt